Let's Stop Talking
And Start Doing
Clinical trials are nothing new, researchers have been conducting them for years. But as the COVID-19 pandemic spread across the world, clinical trials have come into the spotlight, revealing the challenges hampering their progress and success, most notably:
Only about 1% of the US population would consider participating in a clinical trial.
Minority populations are vastly underrepresented in clinical research
50% of Americans are under or uninsured, without access to quality healthcare, and could access care through clinical research at no cost.
Greater Gift works to tackle these challenges by:
▶ Celebrating clinical trial volunteers and doubling their impact to enhance their understanding of the vital role they play in advancing new medications, treatments, and devices.
▶ Developing partnerships with community-based organizations that serve historically marginalized populations to address health disparities, inform communities about opportunities clinical research offers and why it matters to have representative research.
▶ Bridging the gap between the clinical research industry and the non-profit community to engage community health leaders and clinicians serving uninsured/underinsured individuals the opportunity to increase options for access to specialty care through clinical trials.
